会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明授权
    • 8-alkylthio-2-piperazino-pyrimido[5,4-d]-pyrimidines
    • 8-烷硫基-2-哌嗪基 - 嘧啶并[5,4-d] - 嘧啶
    • US4714698A
    • 1987-12-22
    • US745095
    • 1985-06-17
    • Josef RochArmin HeckelJosef NicklErich MullerBerthold NarrRainer ZimmermannJohannes Weisenberger
    • Josef RochArmin HeckelJosef NicklErich MullerBerthold NarrRainer ZimmermannJohannes Weisenberger
    • A61K31/505A61K31/55A61P7/02A61P9/10A61P35/00C07D487/04C07D471/04
    • C07D487/04
    • The invention relates to new compounds of general formula ##STR1## wherein R.sub.1 represents an alkyl group,R.sub.2 represents a hydrogen atom, an alkyl group optionally substituted (except at the .alpha. carbon atom) by a hydroxy group, or represents a cycloalkyl group or an allyl, phenyl or benzyl group,R.sub.3 represents an allyl group, an alkyl group optionally substituted (except at the .alpha. carbon atom) by a hydroxy group, or represents a cycloalkyl group orR.sub.2 and R.sub.3 together with the nitrogen atom between them represent a straight-chained alkyleneimino group,the acid addition salts thereof, particularly the acid addition salts thereof with physiologically acceptable inorganic or organic acids which have valuable pharmacological properties, particularly a metastasis-inhibiting effect based on their selective tumour-PDE inhibiting effect, and pharmaceutical compositions containing these compounds or the physiologically acceptable acid addition salts thereof.The new compounds may be prepared according to methods known for analogous compounds.
    • 本发明涉及通式(I)的新化合物,其中R 1表示烷基,R 2表示氢原子,任选被羟基取代的烷基(除了在α碳原子上),或表示环烷基 基团或烯丙基,苯基或苄基,R 3表示烯丙基,任选被羟基取代的烷基(除了在α碳原子上),或表示环烷基或R 2和R 3以及它们之间的氮原子 代表直链亚烷基亚氨基,其酸加成盐,特别是其酸加成盐与具有有价值的药理学性质的生理上可接受的无机或有机酸,特别是基于其选择性肿瘤-PDE抑制作用的转移抑制作用,以及 含有这些化合物的药物组合物或其生理上可接受的酸加成盐。 新化合物可以根据类似化合物已知的方法制备。
    • 25. 发明授权
    • Indolinones and pharmaceutical compositions containing same
    • 含吲哚酮和含有它们的药物组合物
    • US4629733A
    • 1986-12-16
    • US625020
    • 1984-07-27
    • Erich MullerJosef NicklJosef RochBerthold Narr
    • Erich MullerJosef NicklJosef RochBerthold Narr
    • C07D209/12A61K31/40A61K31/403A61K31/404A61K31/44A61K31/4427A61P7/02C07D209/34C07D401/12
    • C07D209/34
    • The present invention relates to novel indolinones of the general formula ##STR1## wherein R represents an aryl group having from 6 to 10 carbon atoms, unsubstituted or mono- or disubstituted by alkyl groups having from 1 to 5 carbon atoms, hydroxyl groups, alkoxy groups having from 1 to 3 carbon atoms, or halogen atoms, whereby the substituents may be the same or different and whereby the phenyl nucleus of the aryl group may also be substituted by an amino group, a hydroxyl group, or an alkanoylamino group with altogether from 1 to 3 carbon atoms; an aryl group having from 6 to 10 carbon atoms, substituted by 3 or 4 alkyl groups having from 1 to 5 carbon atoms each; a phenyl group substituted by a phenyl, halogenphenyl, or cycloalkyl group with 5 to 7 carbon atoms; an aralkyl group having from 7 to 11 carbon atoms; or a pentamethylphenyl, pyridyl, or quinolyl group; m represents the number 0, 1, or 2; and n represents the number 2, 3, 4, 5, or 6.
    • 本发明涉及通式为“IMAGE”的新的二氢吲哚酮,其中R代表具有6至10个碳原子的芳基,未被取代或被具有1至5个碳原子的烷基单羟基或二取代,羟基,烷氧基 具有1至3个碳原子或卤素原子,其中取代基可以相同或不同,由此芳基的苯基也可以被氨基,羟基或烷酰基氨基取代,其总共从 1至3个碳原子; 具有6至10个碳原子的芳基,被3或4个具有1至5个碳原子的烷基取代; 被苯基,卤素苯基或具有5至7个碳原子的环烷基取代的苯基; 具有7至11个碳原子的芳烷基; 或五甲基苯基,吡啶基或喹啉基; m表示数字0,1或2; n表示数字2,3,4,5或6。
    • 30. 发明授权
    • Biphenylyl derivatives
    • 联苯衍生物
    • US3993683A
    • 1976-11-23
    • US577169
    • 1975-05-14
    • Josef NicklErich MullerBerthold NarrWalter HaarmannWolfgang SchroterRudolf Kadatz
    • Josef NicklErich MullerBerthold NarrWalter HaarmannWolfgang SchroterRudolf Kadatz
    • C07C67/00C07C69/76C07C313/00C07C315/04C07C317/10C07C317/18C07C317/24C07C317/44C07C323/16C07C323/45C07C323/52C07C323/60C07C323/65C07D213/30C07D295/185C07C149/40
    • C07D213/30C07C317/10C07C317/18C07C317/24C07C317/44C07C323/16C07C323/45C07C323/52C07C323/60C07C323/65C07D295/185Y10S514/822
    • Compounds of the formula ##SPC1##WhereinR.sub.1 is hydrogen, fluorine, bromine, methyl, methoxy, methylthio, nitro, cyano or, when A is other than methylene, R.sub.2 is hydrogen, R.sub.3 is carboxyl, m is 2 and n is 0, also chlorine;R.sub.2 is hydrogen or fluorine;R.sub.3 is hydrogen, methyl, hydroxymethyl, carboxyl, (alkoxy of 1 to 6 carbon atoms)-carbonyl, methoxy-(alkoxy of 1 to 6 carbon atoms)-carbonyl, (alkenyloxy of 2 to 6 carbon atoms)-carbonyl, (aralkoxy of 7 to 12 carbon atoms)-carbonyl, phenoxy-carbonyl, pyridylmethoxy-carbonyl, amino-carbonyl, (alkyl of 1 to 3 carbon atoms-amino)-carbonyl, (dialkyl of 1 to 3 carbon atoms-amino)-carbonyl, phenylamino-carbonyl, morpholino-carbonyl, piperidino-carbonyl, thiomorpholino-carbonyl, (1-oxidothiomorpholino)-carbonyl or (1,1-dioxido-thiomorpholino)-carbonyl;A is methylene, (alkyl of 1 to 3 carbon atoms)-methylene, di-(alkyl of 1 to 3 carbon atoms)-methylene, hydroxymethyl-methylene, hydroxymethylene or carbonyl;m is 1 or 2; andn is 0, 1, 2 or 3;And, when R.sub.3 is carboxyl, non-toxic salts thereof formed with an inorganic or organic base. The compounds as well as the salts are useful as antithrombotics, anticholesteremics and anticoagulants.
    • 式A的化合物是氢,氟,溴,甲基,甲氧基,甲硫基,硝基,氰基,或当A不是亚甲基时,R 2是氢,R 3是羧基,m是2,n是0,也是氯; R2是氢或氟; R 3是氢,甲基,羟甲基,羧基,(1至6个碳原子的烷氧基) - 羰基,甲氧基 - (1至6个碳原子的烷氧基) - 羰基,(2至6个碳原子的链烯氧基) - 羰基 7至12个碳原子的羰基,苯氧基 - 羰基,吡啶基甲氧羰基,氨基 - 羰基,(1至3个碳原子的烷基 - 氨基) - 羰基,(1至3个碳原子的二烷基 - 氨基) - 羰基, 苯基氨基羰基,吗啉代羰基,哌啶子基 - 羰基,硫代吗啉代羰基,(1-氧硫基吗啉代)羰基或(1,1-二氧化硫代吗啉代)羰基。 A是亚甲基,(1至3个碳原子的烷基) - 亚甲基,二(1至3个碳原子的烷基) - 亚甲基,羟甲基 - 亚甲基,羟基亚甲基或羰基; M IS 1 OR 2; 和N是0,1,2或3; 当R 3为羧基时,其无机盐与无机或有机碱形成。 化合物以及盐可用作抗血栓形成剂,抗胆固醇剂和抗凝剂。